130 related articles for article (PubMed ID: 23893913)
1. Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.
Tempestilli M; Milano E; D'Offizi G; Montalbano M; D'Avolio A; Gasperi T; Narciso P; Ascenzi P; Pucillo LP
IUBMB Life; 2013 Sep; 65(9):800-5. PubMed ID: 23893913
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC-UV.
Notari S; Tommasi C; Nicastri E; Bellagamba R; Tempestilli M; Pucillo LP; Narciso P; Ascenzi P
IUBMB Life; 2009 Apr; 61(4):470-5. PubMed ID: 19319971
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of lamivudine, lopinavir, ritonavir, and zidovudine concentration in plasma of HIV-infected patients by HPLC-MS/MS.
Notari S; Sergi M; Montesano C; Ivanovic J; Narciso P; Pucillo LP; Ascenzi P
IUBMB Life; 2012 May; 64(5):443-9. PubMed ID: 22473795
[TBL] [Abstract][Full Text] [Related]
5. A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G
J Pharm Biomed Anal; 2013 May; 78-79():217-23. PubMed ID: 23501442
[TBL] [Abstract][Full Text] [Related]
6. Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma.
Chen X; Bushman LR; McAllister KJ; Anderson PL; Kiser JJ
Biomed Chromatogr; 2014 Dec; 28(12):1714-21. PubMed ID: 24760592
[TBL] [Abstract][Full Text] [Related]
7. Highly sensitive determination of HCV protease inhibitors boceprevir (SCH 503034) and telaprevir (VX 950) in human plasma by LC-MS/MS.
Farnik H; El-Duweik J; Welsch C; Sarrazin C; Lötsch J; Zeuzem S; Geisslinger G; Schmidt H
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):4001-6. PubMed ID: 19864192
[TBL] [Abstract][Full Text] [Related]
8. Telaprevir: a hepatitis C NS3/4A protease inhibitor.
Matthews SJ; Lancaster JW
Clin Ther; 2012 Sep; 34(9):1857-82. PubMed ID: 22951253
[TBL] [Abstract][Full Text] [Related]
9. A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevir.
Chen EY; Sclair SN; Czul F; Apica B; Dubin P; Martin P; Lee WM
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1014-20.e1-2. PubMed ID: 23602817
[TBL] [Abstract][Full Text] [Related]
10. Determination of the HCV Protease Inhibitor Telaprevir in Plasma and Dried Blood Spot by Liquid Chromatography-Tandem Mass Spectrometry.
Verweij-van Wissen CP; de Graaff-Teulen MJ; de Kanter CT; Aarnoutse RE; Burger DM
Ther Drug Monit; 2015 Oct; 37(5):626-33. PubMed ID: 25627404
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of triple therapy with telaprevir, peginterferon and ribavirin for elderly patients with genotype 1 chronic hepatitis C.
Hara T; Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Saitoh S; Kumada H
J Med Virol; 2013 Oct; 85(10):1746-53. PubMed ID: 23861088
[TBL] [Abstract][Full Text] [Related]
12. An efficient HPLC method for the quantitative determination of atazanavir in human plasma suitable for bioequivalence and pharmacokinetic studies in healthy human subjects.
Müller AC; Kanfer I
J Pharm Biomed Anal; 2010 Sep; 53(1):113-8. PubMed ID: 20395105
[TBL] [Abstract][Full Text] [Related]
13. High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
Shah VR; Srinivas NR; Campbell DA; Mantha S; Duncan G; Schuster A; Whigan DW; Shyu WC
Biomed Chromatogr; 1996; 10(3):135-8. PubMed ID: 8792865
[TBL] [Abstract][Full Text] [Related]
14. A monolithic-phase based on-line extraction approach for determination of pharmaceutical components in human plasma by HPLC-MS/MS and a comparison with liquid-liquid extraction.
Naxing Xu R; Fan L; Kim GE; El-Shourbagy TA
J Pharm Biomed Anal; 2006 Feb; 40(3):728-36. PubMed ID: 16289933
[TBL] [Abstract][Full Text] [Related]
15. Determination of atazanavir in human plasma using solid-phase extraction and high-performance liquid chromatography.
Cateau E; Tournier N; Dupuis A; Le Moal G; Venisse N
J Pharm Biomed Anal; 2005 Sep; 39(3-4):791-5. PubMed ID: 15927437
[TBL] [Abstract][Full Text] [Related]
16. High performance liquid chromatographic method for the determination of cetirizine and ambroxol in human plasma and urine--a boxcar approach.
Dharuman J; Vasudhevan M; Ajithlal T
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep; 879(25):2624-31. PubMed ID: 21840269
[TBL] [Abstract][Full Text] [Related]
17. Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection.
Loregian A; Scarpa MC; Pagni S; Parisi SG; Palù G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):358-64. PubMed ID: 17574937
[TBL] [Abstract][Full Text] [Related]
18. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
[TBL] [Abstract][Full Text] [Related]
19. Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.
Alves G; Figueiredo I; Castel-Branco M; Loureiro A; Fortuna A; Falcão A; Caramona M
Biomed Chromatogr; 2007 Nov; 21(11):1127-34. PubMed ID: 17594694
[TBL] [Abstract][Full Text] [Related]
20. Early virologic responses and hematologic safety of direct-acting antiviral therapies in veterans with chronic hepatitis C.
Belperio PS; Hwang EW; Thomas IC; Mole LA; Cheung RC; Backus LI
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1021-7. PubMed ID: 23524130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
